Author

Juhan Reimand

Tallinn University of TechnologyORCID 0000-0002-0898-4986Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:imaging· 2 Approach:statistical model· 2

Frequent Co-Authors

Femke H. BouwmaniD· 2 shared Philip ScheltensiD· 2 shared Rik OssenkoppeleiD· 2 shared Albert D. WindhorstiD· 1 shared Antoine LeuzyiD· 1 shared Arno de WildeiD· 1 shared Bart N.M. van BerckeliD· 1 shared Charlotte Elisabeth TeunisseniD· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Femke H. BouwmanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Independent information from PET, CSF and plasma biomarkers of tau pathology in Alzheimer's disease

Rik Ossenkoppele, Juhan Reimand, Ruben A Smith, Antoine Leuzy, Olof T. Strandberg, Sebastian Palmqvist, Erik Stomrud, Henrik Zetterberg, the Alzheimer’s Disease Neuroimaging Initiative, Philip Scheltens, Jeffrey L. Dage, Femke H. Bouwman, Kaj Blennow, Niklas Mattsson, Shorena Janelidze, Oskar Hansson

The paper examines the independent associations of PET, CSF, and plasma tau biomarkers with Alzheimer's disease markers, finding that CSF and plasma p-tau181/p-tau217 are more linked to early AD markers, while tau-PET is strongly associated with cognitive and neurodegenerative progression.

EMBO Molecular Medicine · Jul 13, 2021Peer-reviewedNeuroscience

PET and CSF amyloid-β status are differently predicted by patient features: Information from discordant cases

Juhan Reimand, Arno de Wilde, Charlotte Elisabeth Teunissen, Marissa Deborah Zwan, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Bart N.M. van Berckel, Rik Ossenkoppele, Femke H. Bouwman

The paper finds that patient features differentially predict amyloid-β status based on PET or CSF, with variations by disease stage, suggesting PET and CSF discordance provides unique information.

Alzheimer s Research & Therapy · Dec 1, 2019Peer-reviewedNeuroscience